Form 4 for DYN Dyne Therapeutics, Inc.
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-09 · accession 0001209191-22-060972 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-13 | 2022-12-09 | DYN | McNeill Jonathan | See Remarks | A - Grant | $0.00 | +40.0K | 98.2K | +69% | $0 |
| D | 2022-12-13 | 2022-12-12 | DYN | McNeill Jonathan | See Remarks | S - Sale | $10.87 | -472 | 97.8K | -0.5% | -$5,131 |
| D | 2022-12-13 | 2022-12-09 | DYN | McNeill Jonathan | See Remarks | A - Grant | $0.00 | +63.0K | 63.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-09 | A | A | 40,000 | $0.00 | 98,222 | D | — | — | (F1) Consists of shares of Common Stock issuable under 40,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on March 10, 2023. (F2) Includes 69,072 unvested RSUs. |
| 2 | Common | Common Stock | 2022-12-12 | S | D | 472 | $10.87 | 97,750 | D | — | — | (F3) Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 10, 2021. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person. (F4) Includes 67,490 unvested RSUs. |
| 3 | Derivative | Stock Option (right to buy) | 2022-12-09 | A | A | 63,000 | $0.00 | 63,000 | D | $10.72 · — to 2032-12-08 | 63,000 Common Stock | (F5) This option was granted on December 9, 2022. The shares underlying the option are scheduled to vest over four years in equal monthly installments through December 10, 2026. |